Imagine Everyday Moments With Symptom Relief
You and your doctor can work together to find a medicine that may help improve your symptoms for certain conditions. XELJANZ is a pill approved to treat adults when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used and did not work well or cannot be tolerated. See conditions below:
XELJANZ is approved to treat children ages 2 and older when TNF blockers did not work well or could not be tolerated. See conditions below:
13+ Years in RA
XELJANZ has been prescribed for more than 13 years, since initial approval in 2012, for adults with moderate to severe rheumatoid arthritis.* XELJANZ was approved for use in adults with active psoriatic arthritis* in 2017, adults with moderate to severe ulcerative colitis* in 2018, and adults with active ankylosing spondylitis in 2021.
In 2020, XELJANZ was approved for use in patients ages 2 and older with active polyarticular course juvenile idiopathic arthritis.*
In 2025, XELJANZ was approved for expanded use in children ages 2 and older with active psoriatic arthritis.*
*Indication revised to use in patients who have not responded or cannot tolerate one or more TNF blockers.
Getting Started With XELJANZ
I'm Ready To Talk To My Doctor
I Need Help Affording My Prescription
I Want Support Resources
I’m Ready To Fill My Prescription
Discover Support Resources
The XELJANZ Support Program provides tools and information to help you take an active role in managing your RA with XELJANZ. Sign up to receive emails filled with helpful information and lifestyle suggestions.